Recombinant Human PRAF1 Protein，GST

PRAF1, or phospho-regulated adaptor for the FAK family of proteins 1, is a novel adaptor protein that plays a critical role in various cellular processes, including cell adhesion, migration, and proliferation. Initially identified in studies focusing on the regulation of focal adhesion dynamics, PRAF1 has garnered attention due to its involvement in signaling pathways that intersect with cancer biology and inflammatory responses. Various studies indicate that PRAF1 interacts with several key proteins, such as focal adhesion kinase (FAK) and cortactin, contributing to the assembly of signaling complexes that modulate cytoskeletal rearrangements and affect cell behavior. The overexpression or altered expression patterns of PRAF1 have been implicated in several malignancies, suggesting its potential as a biomarker or therapeutic target in cancer treatment. Additionally, research has revealed that PRAF1 is subject to phosphorylation, which can influence its function and interactions, highlighting the importance of post-translational modifications in regulating its activity. Given the diverse roles of PRAF1 in health and disease, ongoing research aims to elucidate its mechanisms of action, define its functional roles in different cellular contexts, and explore its potential applications in disease modeling and therapeutic interventions. Understanding the structure-function relationship of PRAF1 through recombinant protein studies is essential for developing strategies to manipulate its activity for therapeutic benefit, making PRAF1 a focal point of interest in molecular biology and translational research.